Point72 Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $28M | Buy |
|
|||||
|
2024
Q4 | $17.5M | Buy |
|
|||||
|
2024
Q3 | $13.9M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $118M | Buy |
|
|||||
|
2023
Q4 | $43.9M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $74.2M | Buy |
|
|||||
|
2022
Q3 | $50.5M | Buy |
|
|||||
|
2022
Q2 | $12.3M | Sell |
|
|||||
|
2022
Q1 | $28.3M | Sell |
|
|||||
|
2021
Q4 | $72.6M | Buy |
|
|||||
|
2021
Q3 | $61.2M | Buy |
|
|||||
|
2021
Q2 | $30.6M | Buy |
|
|||||
|
2021
Q1 | $19.4M | Sell |
|
|||||
|
2020
Q4 | $33.4M | Sell |
|
|||||
|
2020
Q3 | $71.8M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $22M | Buy |
|
|||||
|
2019
Q3 | $4.36M | Sell |
|
|||||
|
2019
Q2 | $21.6M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $5.06M | Sell |
|
|||||
|
2018
Q1 | $20.4M | Sell |
|
|||||
|
2017
Q4 | $44.3M | Sell |
|
|||||
|
2017
Q3 | $71.6M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $32M | Sell |
|
|||||
|
2016
Q4 | $43.6M | Buy |
|
|||||
|
2016
Q3 | $14.2M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $6.74M | Sell |
|
|||||
|
2014
Q3 | $48.8M | Buy |
|
|||||
|
2014
Q2 | $5.61M | Buy |
|